Ulcerative colitis is a chronic, immune-mediated inflammatory bowel disease affecting the large intestine, causing persistent inflammation and ulceration of the colon’s lining. Common symptoms include ...

The Boston Pen People, a group of fountain pen enthusiasts, gathers quarterly to commune, write and celebrate the historical significance and practical benefits of their beloved writing instruments.

Oct 31 (Reuters) - AbbVie (ABBV.N), opens new tab said on Friday the Trump administration was pushing for steeper cuts in this year's Medicare drug price negotiations, which in 2024 yielded discounts ...

Skyrizi (risankizumab-rzaa) is a prescription drug used to treat certain autoimmune conditions, including plaque psoriasis and Crohn’s disease. It works by attaching to specific proteins in your ...

Skyrizi (risankizumab-rzaa) is a biologic medication doctors prescribe to treat certain autoimmune and inflammatory conditions. Like any medication, it can cause side effects. But is one of Skyrizi’s ...

Your Ozempic pen may still look full because it has extra liquid for a one-time flow check. To check whether you have another dose, turn the dose selector. If it stops at your full dose, you have ...

Samsung’s new Galaxy Tab S11 has arrived with updated specs, the return of an 11-inch size, and some big S Pen changes. The Galaxy Tab S11 series will feel pretty similar to anyone who has seen the ...

AbbVie ABBV delivered encouraging second-quarter 2025 results last week, sending a clear message — it is effectively managing its post-Humira transition. The stronger-than-expected sales of newer ...

AbbVie sees limited tariff impact due to U.S. manufacturing Skyrizi and Rinvoq sales exceed analyst expectations Venclexta to benefit from Trump's "one big beautiful bill" July 31 (Reuters) - AbbVie ...

AbbVie’s ABBV2.10%increase; green up pointing triangle beat Wall Street’s estimates for its top- and bottom-lines in the second quarter, boosted by sales of Skyrizi and Rinvoq. The North Chicago, Ill.